Published in Eur Neurol on January 01, 1997
Animal models of focal dystonia. NeuroRx (2005) 0.80
Animal models for investigating benign essential blepharospasm. Curr Neuropharmacol (2013) 0.77
Circadian Change in Blink Reflex Recovery in Restless Legs Syndrome. Noro Psikiyatr Ars (2016) 0.75
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol (1993) 7.27
Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell (1996) 3.00
White matter hyperintensities in Parkinson's disease. Clinical correlations. Arch Neurol (1995) 2.30
Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06
Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell (1989) 1.96
Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol (2004) 1.80
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76
A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int (1994) 1.60
IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study. Neurology (2003) 1.60
Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology (2002) 1.51
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology (2008) 1.50
Receptor-mediated phosphorylation of the hepatic insulin receptor: evidence that the Mr 95,000 receptor subunit is its own kinase. Proc Natl Acad Sci U S A (1983) 1.49
White matter MRI hyperintensities in a hundred and twenty-nine consecutive migraine patients. Cephalalgia (1994) 1.49
Intensity modulated proton therapy: a clinical example. Med Phys (2001) 1.49
Surgical treatment of tuberculous spondylodiscitis. Eur Rev Med Pharmacol Sci (2012) 1.49
Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst (1999) 1.48
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma. J Hematother Stem Cell Res (2000) 1.37
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci (2005) 1.30
Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood (2001) 1.28
Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun (2000) 1.28
Elastofibroma dorsi: 8 case reports and a literature review. J Orthop Traumatol (2008) 1.26
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr (1995) 1.25
A hybrid approach to EMG pattern analysis for classification of arm movements using statistical and fuzzy techniques. Med Eng Phys (1999) 1.24
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry (2004) 1.20
EFNS guidelines on cognitive rehabilitation: report of an EFNS task force. Eur J Neurol (2005) 1.17
Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A (1988) 1.16
Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect Immun (2001) 1.16
Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer (1991) 1.15
Characterization of a cDNA clone coding for human testis membrane cofactor protein (MCP, CD46). Mol Reprod Dev (1993) 1.13
Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J Biol Chem (1994) 1.13
Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J (1996) 1.13
Psychiatric comorbidity and psychosocial stress in patients with tension-type headache from headache centers in Italy. The Italian Collaborative Group for the Study of Psychopathological Factors in Primary Headaches. Cephalalgia (1999) 1.13
Paroxetine in Parkinson's disease: effects on motor and depressive symptoms. Neurology (2000) 1.11
Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J Leukoc Biol (2000) 1.09
Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood (2001) 1.09
Escherichia coli cytotoxic necrotizing factor 1 effaces microvilli and decreases transmigration of polymorphonuclear leukocytes in intestinal T84 epithelial cell monolayers. Infect Immun (1998) 1.09
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord (2001) 1.05
Resection of parosteal osteosarcoma of the distal part of the femur: an original reconstruction technique with cement and plate. Sarcoma (2008) 1.05
Sustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cells. J Cell Biol (2000) 1.05
Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study. Mov Disord (2001) 1.03
Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol (1997) 1.01
Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol (1993) 1.01
Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun (2001) 1.00
Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol (1999) 1.00
Joubert syndrome with associated corpus callosum agenesis. Eur J Paediatr Neurol (2002) 0.99
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy. J Neurol Sci (1995) 0.98
Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand (2007) 0.98
Receptor cross-linking restores an insulin metabolic effect altered by mutation on tyrosine 1162 and tyrosine 1163. Biochemistry (1989) 0.97
Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients. Cytogenet Cell Genet (1999) 0.97
Induction of tyrosine phosphorylation and T-cell activation by vanadate peroxide, an inhibitor of protein tyrosine phosphatases. Biochem J (1994) 0.97
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurol Sci (2001) 0.97
Use of an anti-insulin receptor antibody to discriminate between metabolic and mitogenic effects of insulin: correlation with receptor autophosphorylation. EMBO J (1988) 0.97
SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. Clin Neuropharmacol (2001) 0.96
Epidemiology of multiple system atrophy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci (2001) 0.96
The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord (2012) 0.96
CD3-stimulated Jurkat T cells mediate IL-1 beta production in monocytic THP-1 cells. Role of LFA-1 molecule and participation of CD69 T cell antigen. Eur Cytokine Netw (1993) 0.95
Insulin and rabbit anti-insulin receptor antibodies stimulate additively the intrinsic receptor kinase activity. EMBO J (1987) 0.95
Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J Biol Chem (2001) 0.94
Effect of Helicobacter pylori on polymorphonuclear leukocyte migration across polarized T84 epithelial cell monolayers: role of vacuolating toxin VacA and cag pathogenicity island. Infect Immun (2000) 0.94
Characterization of ouabain-resistant mutants of a canine kidney cell line, MDCK. J Biol Chem (1983) 0.94
Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. Acta Paediatr (1992) 0.93
Pseudosubstrates of the sarcoplasmic Ca2+-ATPase as tools to study the coupling between substrate hydrolysis and Ca2+ transport. J Biol Chem (1979) 0.93
Clinical diagnosis of multiple system atrophy: level of agreement between Quinn's criteria and the consensus conference guidelines. Acta Neurol Scand (2001) 0.92
(Na+, K+)-activated adenosinetriphosphatase of axonal membranes, cooperativity and control. Steady-state analysis. Eur J Biochem (1976) 0.92
Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction. Oncogene (1998) 0.92
Acute and chronic effects of clozapine in essential tremor. Mov Disord (1999) 0.92
A case of sarcoidosis presenting as a non-specific intramedullary lesion. Eur J Neurol (2007) 0.92
Skeletal muscle and nutritional assessment in chronic renal failure patients on a protein-restricted diet. J Intern Med (2004) 0.92
Improvement of motor function in early Parkinson disease by safinamide. Neurology (2004) 0.91
Clinical outcome and magnetic resonance imaging of carbon monoxide intoxication. A long-term follow-up study. Ital J Neurol Sci (1999) 0.91
The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread. J Neurol (2014) 0.91
Epidemiological and clinical features of pyogenic spondylodiscitis. Eur Rev Med Pharmacol Sci (2012) 0.91
Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease. Hum Genet (1997) 0.90
Expression of decay-accelerating factor (CD55) of the complement system on human spermatozoa. J Immunol (1993) 0.90
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. Oncogene (1997) 0.89
Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production. J Biol Chem (1998) 0.89
Paraneoplastic choreic syndrome during non-Hodgkin's lymphoma. Mov Disord (2000) 0.89
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study. Eur J Neurol (2009) 0.89
A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol (2008) 0.88
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports. J Neurol Neurosurg Psychiatry (2001) 0.88
Human monocytes express amphiregulin and heregulin growth factors upon activation. Eur Cytokine Netw (1997) 0.88
N-linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling. J Biol Chem (1992) 0.88
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy. Parkinsonism Relat Disord (2004) 0.87
Diffusion tensor MRI and MR spectroscopy in long lasting upper motor neuron involvement in amyotrophic lateral sclerosis. Arch Ital Biol (2009) 0.87
HIV-1 nef expression inhibits the activity of a Ca2+-dependent K+ channel involved in the control of the resting potential in CEM lymphocytes. J Immunol (1999) 0.87
Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. J Neural Transm (Vienna) (2004) 0.86
Lack of internucleosomal DNA fragmentation is related to Cl(-) efflux impairment in hematopoietic cell apoptosis. FASEB J (1999) 0.86
Affinity labeling of the digitalis receptor with p-nitrophenyltriazene-ouabain, a highly specific alkylating agent. J Biol Chem (1980) 0.86
Analgesic effectiveness of caudal levobupivacaine and ketamine. Br J Anaesth (2008) 0.86
Amantadine in Huntington's disease: open-label video-blinded study. Neurol Sci (2002) 0.86
HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules. Eur J Immunol (1996) 0.86
Gynecomastia in epileptics treated with phenobarbital, phenytoin and fluoresone: two case reports. Ital J Neurol Sci (1983) 0.86
Protein kinase activation by warm and cold hypoxia- reoxygenation in primary-cultured rat hepatocytes-JNK(1)/SAPK(1) involvement in apoptosis. Hepatology (2000) 0.86